価格表

在庫・価格 : 2025年04月26日 20時39分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-VEGF, Rat, Goat-Poly
データシート※最新のデータシートでない場合があります
AF564 RSDアールアンドディー システムズ
R&D Systems, Inc.
100 μg ¥105,000
(未発注)
追加

在庫・価格 : 2025年04月26日 20時39分 現在

Anti-VEGF, Rat, Goat-Poly

  • 商品コード:AF564
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥105,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Wick A et al. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neurosci. 2002 Aug;22(15):6401-7
Wick A et al
2002/01/01
Species: Rat, Application: Neutralization, Sample type: Whole Cells PubMed
2 Carpenter T et al. Endothelin B receptor deficiency predisposes to pulmonary edema formation via increased lung vascular endothelial cell growth factor expression. Circ. Res. 2003 Sep;93(5):456-63
Carpenter T et al
2003/01/01
Application: Neutralization PubMed
3 Io H et al. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int. 2004 May;65(5):1927-36
Io H et al
2004/01/01
Application: In vivo PubMed
4 Nicosia RF et al. A new ex vivo model to study venous angiogenesis and arterio-venous anastomosis formation. J. Vasc. Res. ;42(2):111-9
Nicosia RF et al
Application: Neutralization, Sample Type: Whole Tissue PubMed
5 Ijichi H et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy. J. Hepatol. 2006 Jul;45(1):28-34
Ijichi H et al
2006/01/01
Species: Rat, Application: Western Blot, Sample type: Homogenized Tissue PubMed
6 Zen K et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J. Mol. Cell. Cardiol. 2006 Jun;40(6):799-809
Zen K et al
2006/01/01
Species: Rat, Application: Western Blot, Sample type: Cell Lysates PubMed
7 Shimojo N et al. Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2007 Jul;293(1):H474-81
Shimojo N et al
2007/01/01
Species: Rat, Application: Neutralization, Sample type: Whole Cells PubMed
8 Yeh WL et al. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol. Pharmacol. 2007 Aug;72(2):440-9
Yeh WL et al
2007/01/01
Species: Rat, Application: Neutralization, Sample type: Whole Cells PubMed
9 Baron-Menguy C et al. Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J. 2007 Nov;21(13):3511-21
Baron-Menguy C et al
2007/01/01
Species: Rat, Application: Neutralization, Sample type: In Vivo PubMed
10 ten Dam GB et al. Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding. Am. J. Pathol. 2007 Oct;171(4):1324-33
ten Dam GB et al
2007/01/01
Species: Rat, Application: ELISA Development, Sample type: recombinant VEGF PubMed
11 Advani A et al. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc. Natl. Acad. Sci. U.S.A. 2007 Sep;104(36):14448-53
Advani A et al
2007/01/01
Species: Rat, Application: Neutralization, Sample type: In Vivo PubMed
12 Yeh WL et al. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 2008 Jan;73(1):170-7
Yeh WL et al
2008/01/01
Species: Rat, Application: Neutralization, Sample type: Cell Supernates PubMed
13 Heineke J et al. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J. Clin. Invest. 2007 Nov;117(11):3198-210
Heineke J et al
2007/01/01
Species: Mouse, Application: Western Blot, Sample type: Cell Lysates, Cell Supernates, Homogenized Tissue PubMed
14 Hartnett ME et al. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest. Ophthalmol. Vis. Sci. 2008 Jul;49(7):3107-14
Hartnett ME et al
2008/01/01
Species: Rat, Application: Neutralization, In Vivo PubMed
15 Marko SB et al. VEGF promotes vascular sympathetic innervation. Am. J. Physiol. Heart Circ. Physiol. 2008 Jun;294(6):H2646-52
Marko SB et al
2008/01/01
Species: Rat, Application: IHC Fresh, Neutralization, Whole Cells, Whole Tissue, In Vivo PubMed
16 Lin HH et al. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J. Mol. Cell. Cardiol. 2008 Jul;45(1):44-55
Lin HH et al
2008/01/01
Species: Mouse, Application: Neutralization, In Vivo PubMed
17 Sato W et al. The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy. Lab. Invest. 2008 Sep;88(9):949-61
Sato W et al
2008/01/01
Species: Rat, Application: IHC Paraffin-embedded, Whole Tissue PubMed
18 Kaliappan S et al. Alcohol and nicotine consumption exacerbates choroidal neovascularization by modulating the regulation of complement system. FEBS Lett. 2008 Oct;582(23-24):3451-8
Kaliappan S et al
2008/01/01
Application: IHC Paraffin, Sample Type: Whole Tissue PubMed
19 Kosugi T et al. Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice. Am. J. Pathol. 2009 Apr;174(4):1221-9
Kosugi T et al
2009/01/01
Application: IHC Paraffin-embedded,Western Blot, Sample Type: Cell Lysates,Whole Tissue PubMed
20 Irani Y et al. Production of scFv antibody fragments from a hybridoma with functional activity against human vascular endothelial growth factor. Hybridoma (Larchmt) 2009 Jun;28(3):205-9
Irani Y et al
2009/01/01
Application: Binding Assay, Sample Type: recombinant protein PubMed
21 Westenbrink BD et al. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc. Res. 2010 Jul;87(1):30-9
Westenbrink BD et al
2010/01/01
Application: Neutralization, Sample Type: In Vivo,Whole Cells PubMed
22 McCloskey M et al. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2013 Mar;54(3):2020-6
McCloskey M et al
2013/01/01
Application: In vivo, Sample Type: In Vivo PubMed
23 Dharmani P et al. The probiotic mixture VSL#3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor. PLoS ONE 2013;8(3):e58671
Dharmani P et al
2013/01/01
Application: Neutralization, Sample Type: tissues PubMed
24 Daniel C et al. Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy. PLoS ONE 2013;8(12):e83846
Daniel C et al
2013/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
25 Chen H et al. Pre-activation of mesenchymal stem cells with TNF-α, IL-1β and nitric oxide enhances its paracrine effects on radiation-induced intestinal injury. Sci Rep 2015;5:8718
Chen H et al
2015/01/01
Application: Neutralization, Sample Type: Conditioned media PubMed
26 Wang H et al. Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2014 Feb;55(2):737-44
Wang H et al
2014/01/01
Application: In vivo, Sample Type: In Vivo PubMed
27 Imberti B et al. Renal primordia activate kidney regenerative events in a rat model of progressive renal disease. PLoS ONE 2015;10(3):e0120235
Imberti B et al
2015/01/01
Application: IHC Not Specified, Sample Type: Whole Tissue PubMed
28 Deliyanti D et al. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy. PLoS ONE 2015;10(7):e0134392
Deliyanti D et al
2015/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
29 Ma C et al. A multifunctional bioactive material that stimulates osteogenesis and promotes the vascularization bone marrow stem cells and their resistance to bacterial infection. PLoS ONE 2017;12(3):e0172499
Ma C et al
2017/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
30 Melly L et al. Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels. J. Cell. Mol. Med. 2018 May;22(5):2580-2591
Melly L et al
2018/01/01
Species: Rat, Applications: IHC-F PubMed
31 Lind T et al. Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy <i>Vegfa</i> overexpression. Bone Rep 2018 Dec;9:27-36
Lind T et al
2018/01/01
Species: Rat, Applications: IHC PubMed
32 Mirabelli P et al. Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. Sci Rep 2017 Aug;7(1):7616
Mirabelli P et al
2017/01/01
Species: Rat, Applications: Neut PubMed
33 Al Asoom LI. Coronary angiogenic effect of long-term administration of Nigella sativa. BMC Complement Altern Med 2017 Jun;17(1):308
Al Asoom LI
2017/01/01
PubMed
34 Khalili S et al. The effect of a single anti-Vascular Endothelial Growth Factor injection on neonatal growth and organ development: In-vivo study. Exp Eye Res 2018 04;169:54-59
Khalili S et al
2018/01/01
PubMed
35 Asano D et al. Cellular Mechanisms of Angiogenesis in Neonatal Rat Models of Retinal Neurodegeneration. Int J Mol Sci 2019 Sep;20(19)
Asano D et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Wick A et al. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neurosci. 2002 Aug;22(15):6401-7
    Wick A et al
    2002/01/01
  • 備考:
    Species: Rat, Application: Neutralization, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Carpenter T et al. Endothelin B receptor deficiency predisposes to pulmonary edema formation via increased lung vascular endothelial cell growth factor expression. Circ. Res. 2003 Sep;93(5):456-63
    Carpenter T et al
    2003/01/01
  • 備考:
    Application: Neutralization
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Io H et al. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int. 2004 May;65(5):1927-36
    Io H et al
    2004/01/01
  • 備考:
    Application: In vivo
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Nicosia RF et al. A new ex vivo model to study venous angiogenesis and arterio-venous anastomosis formation. J. Vasc. Res. ;42(2):111-9
    Nicosia RF et al
  • 備考:
    Application: Neutralization, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Ijichi H et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy. J. Hepatol. 2006 Jul;45(1):28-34
    Ijichi H et al
    2006/01/01
  • 備考:
    Species: Rat, Application: Western Blot, Sample type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Zen K et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J. Mol. Cell. Cardiol. 2006 Jun;40(6):799-809
    Zen K et al
    2006/01/01
  • 備考:
    Species: Rat, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Shimojo N et al. Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2007 Jul;293(1):H474-81
    Shimojo N et al
    2007/01/01
  • 備考:
    Species: Rat, Application: Neutralization, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Yeh WL et al. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol. Pharmacol. 2007 Aug;72(2):440-9
    Yeh WL et al
    2007/01/01
  • 備考:
    Species: Rat, Application: Neutralization, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Baron-Menguy C et al. Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J. 2007 Nov;21(13):3511-21
    Baron-Menguy C et al
    2007/01/01
  • 備考:
    Species: Rat, Application: Neutralization, Sample type: In Vivo
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    ten Dam GB et al. Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding. Am. J. Pathol. 2007 Oct;171(4):1324-33
    ten Dam GB et al
    2007/01/01
  • 備考:
    Species: Rat, Application: ELISA Development, Sample type: recombinant VEGF
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Advani A et al. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc. Natl. Acad. Sci. U.S.A. 2007 Sep;104(36):14448-53
    Advani A et al
    2007/01/01
  • 備考:
    Species: Rat, Application: Neutralization, Sample type: In Vivo
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Yeh WL et al. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 2008 Jan;73(1):170-7
    Yeh WL et al
    2008/01/01
  • 備考:
    Species: Rat, Application: Neutralization, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Heineke J et al. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J. Clin. Invest. 2007 Nov;117(11):3198-210
    Heineke J et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: Western Blot, Sample type: Cell Lysates, Cell Supernates, Homogenized Tissue
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Hartnett ME et al. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest. Ophthalmol. Vis. Sci. 2008 Jul;49(7):3107-14
    Hartnett ME et al
    2008/01/01
  • 備考:
    Species: Rat, Application: Neutralization, In Vivo
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Marko SB et al. VEGF promotes vascular sympathetic innervation. Am. J. Physiol. Heart Circ. Physiol. 2008 Jun;294(6):H2646-52
    Marko SB et al
    2008/01/01
  • 備考:
    Species: Rat, Application: IHC Fresh, Neutralization, Whole Cells, Whole Tissue, In Vivo
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Lin HH et al. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J. Mol. Cell. Cardiol. 2008 Jul;45(1):44-55
    Lin HH et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Neutralization, In Vivo
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Sato W et al. The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy. Lab. Invest. 2008 Sep;88(9):949-61
    Sato W et al
    2008/01/01
  • 備考:
    Species: Rat, Application: IHC Paraffin-embedded, Whole Tissue
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Kaliappan S et al. Alcohol and nicotine consumption exacerbates choroidal neovascularization by modulating the regulation of complement system. FEBS Lett. 2008 Oct;582(23-24):3451-8
    Kaliappan S et al
    2008/01/01
  • 備考:
    Application: IHC Paraffin, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Kosugi T et al. Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice. Am. J. Pathol. 2009 Apr;174(4):1221-9
    Kosugi T et al
    2009/01/01
  • 備考:
    Application: IHC Paraffin-embedded,Western Blot, Sample Type: Cell Lysates,Whole Tissue
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Irani Y et al. Production of scFv antibody fragments from a hybridoma with functional activity against human vascular endothelial growth factor. Hybridoma (Larchmt) 2009 Jun;28(3):205-9
    Irani Y et al
    2009/01/01
  • 備考:
    Application: Binding Assay, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Westenbrink BD et al. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc. Res. 2010 Jul;87(1):30-9
    Westenbrink BD et al
    2010/01/01
  • 備考:
    Application: Neutralization, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    McCloskey M et al. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2013 Mar;54(3):2020-6
    McCloskey M et al
    2013/01/01
  • 備考:
    Application: In vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Dharmani P et al. The probiotic mixture VSL#3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor. PLoS ONE 2013;8(3):e58671
    Dharmani P et al
    2013/01/01
  • 備考:
    Application: Neutralization, Sample Type: tissues
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Daniel C et al. Long-term gene therapy with thrombospondin 2 inhibits TGF-&#x3B2; activation, inflammation and angiogenesis in chronic allograft nephropathy. PLoS ONE 2013;8(12):e83846
    Daniel C et al
    2013/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Chen H et al. Pre-activation of mesenchymal stem cells with TNF-&#x3B1;, IL-1&#x3B2; and nitric oxide enhances its paracrine effects on radiation-induced intestinal injury. Sci Rep 2015;5:8718
    Chen H et al
    2015/01/01
  • 備考:
    Application: Neutralization, Sample Type: Conditioned media
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Wang H et al. Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2014 Feb;55(2):737-44
    Wang H et al
    2014/01/01
  • 備考:
    Application: In vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Imberti B et al. Renal primordia activate kidney regenerative events in a rat model of progressive renal disease. PLoS ONE 2015;10(3):e0120235
    Imberti B et al
    2015/01/01
  • 備考:
    Application: IHC Not Specified, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Deliyanti D et al. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy. PLoS ONE 2015;10(7):e0134392
    Deliyanti D et al
    2015/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Ma C et al. A multifunctional bioactive material that stimulates osteogenesis and promotes the vascularization bone marrow stem cells and their resistance to bacterial infection. PLoS ONE 2017;12(3):e0172499
    Ma C et al
    2017/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Melly L et al. Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels. J. Cell. Mol. Med. 2018 May;22(5):2580-2591
    Melly L et al
    2018/01/01
  • 備考:
    Species: Rat, Applications: IHC-F
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Lind T et al. Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy <i>Vegfa</i> overexpression. Bone Rep 2018 Dec;9:27-36
    Lind T et al
    2018/01/01
  • 備考:
    Species: Rat, Applications: IHC
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Mirabelli P et al. Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. Sci Rep 2017 Aug;7(1):7616
    Mirabelli P et al
    2017/01/01
  • 備考:
    Species: Rat, Applications: Neut
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Al Asoom LI. Coronary angiogenic effect of long-term administration of Nigella sativa. BMC Complement Altern Med 2017 Jun;17(1):308
    Al Asoom LI
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Khalili S et al. The effect of a single anti-Vascular Endothelial Growth Factor injection on neonatal growth and organ development: In-vivo study. Exp Eye Res 2018 04;169:54-59
    Khalili S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Asano D et al. Cellular Mechanisms of Angiogenesis in Neonatal Rat Models of Retinal Neurodegeneration. Int J Mol Sci 2019 Sep;20(19)
    Asano D et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed